Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of BLZ-100 Administered by Intravenous Injection in Subjects With Soft Tissue Sarcoma Undergoing Surgery

NCT02464332 is registered in ClinicalTrials.gov with Blaze Bioscience Inc. as lead sponsor.

NCT NCT02464332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of BLZ-100 Administered by Intravenous Injection in Subjects With Soft Tissue Sarcoma Undergoing Surgery
Lead sponsor
Blaze Bioscience Inc.
Phase
Phase 1
Overall status
Withdrawn
Start date
September 30, 2015
Completion date
May 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue